Nathaniel Weygant
机构: Professor, Fujian University of Traditional Chinese Medicine
每年引用次数
引用次数
引用: 2,005
H-指数: 28
I10-指数 : 34
出版物: 113
DCLK1 is part of an EMT feedback loop and promotes colorectal cancer cell invasion and drug resistance
Dongfeng Qu , Nathaniel Weygant , William L Berry , Randal May
Cancer Research 77 ( 13_Supplement) 3888 -3888
2017
Targeting tumor/cancer stem cell marker DCLK1 for the treatment of hepatocellular carcinoma and erlotinib-resistant lung adenocarcinoma using Z-3, 5, 4’-Trimethoxystilbene (Z-TMS)
Naushad Ali , Charles B Nguyen , Sanam Husain , Parthasarathy Chandrakesan
Cancer Research 76 ( 14_Supplement) 3361 -3361
2016
Overexpression of DCLK1 in pancreatic cancer activates KRAS/PI3K/MTOR pathway signaling and supports tumorigenesis, invasiveness, and stemness
Dongfeng Qu , Nathaniel Weygant , Randal May , William Berry
Cancer Research 76 ( 14_Supplement) 1731 -1731
2016
Doublecortin-like kinase 1 marks cancer stem-like cells and modulates drug-resistance, self-renewal, and tumorigenesis in renal cancer
Yang Ge , Nathaniel Weygant , Dongfeng Qu , Randal May
Cancer Research 76 ( 14_Supplement) 3340 -3340
2016
and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression
Charles B Nguyen , Hari Kotturi , Gulam Waris , Altaf Mohammed
2016
High Tumor DCLK1 Levels at Colorectal Cancer Diagnosis Predict Poor Survival: 1253
Nathaniel Weygant , Kenneth J Vega , Courtney Houchen
Official journal of the American College of Gastroenterology| ACG 110 S550 -S551
2015
The tumor stem cell marker doublecortin-like kinase (DCLK1) activates inflammatory and carcinogenic signals in hepatocellular carcinoma
Naushad Ali , Parthasarathy Chandrakesan , Charles B Nguyen , Sanam Husain
Cancer Research 75 ( 15_Supplement) 2239 -2239
2015
DCLK1 targeted monoclonal antibodies demonstrate therapeutic potential against pancreatic ductal adenocarcinoma
Dongfeng Qu , Nathaniel Weygant , Randal May , Parthasarathy Chandrakesan
CANCER RESEARCH 74 ( 19)
2014
Overexpression of a cancer stem cell marker doublecortin-like kinase (DCLK1) leads to activation of inflammatory cascade during development of virus-induced hepatocellular carcinoma
Naushad Ali , Parthasarathy Chandrakesan , Mark Huycke , Sanam Husain
Cancer Research 74 ( 19_Supplement) 3171 -3171
2014
Trimethoxy-cis-stilbene exhibits potent anti-tumor activities via suppression of AKT signaling and cell cycle arrest in virus-induced hepatocellular carcinoma
Charles Nguyen , Hari Kotturi , Sripathi Sureban , Randal J May
Cancer Research 74 ( 19_Supplement) 4552 -4552
2014
Correction: Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
Naushad Ali , Heba Allam , Ted Bader , Randal May
Plos one 8 ( 12)
2013
OK, USA
Charles B Nguyen , Hari Kotturi , Gulam Waris , Altaf Mohammed
Bufalin inhibits tumorigenesis, stemness, and epithelial–mesenchymal transition in colorectal cancer through a C-Kit/Slug signaling axis
Ling Ding , Yuning Yang , Qin Lu , Dongfeng Qu
International Journal of Molecular Sciences 23 ( 21) 13354 -13354
7
2022
DCLK1-short splice variant promotes esophageal squamous cell carcinoma progression via the MAPK/ERK/MMP2 pathway
Yang Ge , Xiaona Fan , Xuying Huang , Nathaniel Weygant
Molecular Cancer Research 19 ( 12) 1980 -1991
11
2021
Applications of organoid technology to brain tumors
Jie Wen , Fangkun Liu , Quan Cheng , Nathaniel Weygant
CNS Neuroscience & Therapeutics 29 ( 10) 2725 -2743
9
2023
Differential dermatologic adverse events associated with checkpoint inhibitor monotherapy and combination therapy: a meta-analysis of randomized control trials
Yang Ge , Huiyun Zhang , Nathaniel Weygant , Jiannan Yao
Frontiers in Pharmacology 12 640099 -640099
5
2021
Establishment of a competing risk nomogram in patients with pulmonary sarcomatoid carcinoma
Ziwei Liang , Enyu Zhang , Ling Duan , Nathaniel Weygant
Technology in Cancer Research & Treatment 21 15330338211068960 -15330338211068960
3
2022
DCLK1 and tuft cells: Immune-related functions and implications for cancer immunotherapy
Ling Ding , Nathaniel Weygant , Chenhuan Ding , Yi Lai
Critical Reviews in Oncology/Hematology 104118 -104118
1
2023
Doublecortin-like kinase 1 as a novel drug target and biomarker in gastrointestinal and renal cancers
Nathaniel Weygant
University of Portsmouth
1
2018
Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids
Hong Chen , Yuping Yang , Jinsen Shi , Ting Yan
Current Cancer Drug Targets 24 ( 5) 546 -555
2024